Saturday 17 October 2026
Export ATR’s income statement to Excel — free account
AptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024. In the quarter to June 2026, revenue grew 6.26%, EPS fell 18.3%, free cash flow fell 23.1% and total debt rose 66.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten.
124.51
0.25
+0.20%
Follow ATR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
15.70% | 15.19% | 14.87% | 13.52% | |
Piotroski F-Score |
7 | 5 | 6 | 6 | |
| 8.62% | 8.11% | 8.03% | 7.25% | ||
ROIC |
8.64% | 8.33% | 8.18% | 7.82% | |
Return on Tangible Assets |
21.80% | 16.34% | 16.34% | 15.46% | |
Average Days of Receivables |
79.63 | 77.68 | 78.53 | 83.30 | |
Free Cash Flow per Share |
4.70 | 4.53 | 5.13 | 4.94 | |
Free Cash Flow |
308.70 | 298.11 | 328.66 | 314.58 | |
Capital Expenditures |
(255.84) | (271.89) | (277.29) | (268.89) | |
| Other line items | |||||
Cash ROIC |
7.26% | 6.51% | 7.75% | 7.47% | |
Accounts Receivable Turnover |
4.89 | 5.17 | 4.91 | 4.63 | |
Accounts Payable Turnover |
2.80 | 3.06 | 3.06 | 2.95 | |
Inventory Turnover |
4.38 | 4.75 | 4.74 | 4.54 | |
Average Days of Payables |
136.01 | 126.60 | 125.14 | 128.80 | |
Days of Inventory on Hand |
88.13 | 82.75 | 82.08 | 84.21 | |
Tax Rate |
(0.19) | (0.20) | (0.19) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.21% | 16.06% | 15.98% | 15.90% | |
Share Based Compensation of Revenue |
1.27% | 1.16% | 1.07% | 1.04% | |
Interest Coverage |
10.93 | 9.50 | 8.49 | 7.52 | |
Operating CF/Net income |
1.35 | 1.45 | 1.57 | 1.61 | |
Depreciation/Fixed assets |
0.17 | 0.17 | 0.18 | 0.19 | |
Capex/Depreciation |
(0.92) | (0.95) | (0.93) | (0.88) | |
Revenue per Share |
55.74 | 57.46 | 60.46 | 61.81 | |
Operating CF per Share |
8.59 | 8.67 | 9.46 | 9.17 | |
Capex per Share |
(3.89) | (4.14) | (4.33) | (4.23) | |
Capex to Sales |
0.07 | 0.07 | 0.07 | 0.07 |
Columns are period end dates